Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells. [electronic resource]
Producer: 20050516Description: 249-53 p. digitalISSN:- 0250-7005
- Actins -- metabolism
- Angiogenesis Inhibitors -- pharmacology
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cytoskeleton -- drug effects
- Endothelial Cells -- cytology
- Female
- Fenretinide -- pharmacology
- Focal Adhesion Kinase 1
- Focal Adhesion Protein-Tyrosine Kinases
- Humans
- Neoplasm Invasiveness
- Neovascularization, Pathologic -- drug therapy
- Ovarian Neoplasms -- blood supply
- Phosphorylation -- drug effects
- Protein-Tyrosine Kinases -- metabolism
- Umbilical Veins -- cytology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.